Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients
β Scribed by Brusa, L.; Musco, S.; Bernardi, G.; Iani, C.; Pierantozzi, M.; Stanzione, P.; Stefani, A.; Finazzi Agro', E.
- Book ID
- 122870210
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 321 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The objective of this study was to determine the effects of rasagiline as monotherapy on quality of life (QOL) in patients with early Parkinson's disease (PD). Rasagiline, a potent, second-generation, irreversible, selective monoamine oxidase B inhibitor improves PD symptoms in patients with early P
## Abstract Rasagiline (__N__βpropargylβ1(__R__)βaminoindan) mesylate is a potent, selective, and irreversible monoamine oxidaseβB inhibitor. This study was designed to evaluate the safety, tolerability, and preliminary efficacy of rasagiline monotherapy in early Parkinson's disease (PD) patients n